NTRK1 and neoplasm: Furthermore, Schmid et al. 36, demonstrated a role for p110γ in regulating tumour inflammation initiated by a range of ligands coupling to receptor tyrosine kinases; VEGF-A, toll like/interleukin-1 receptors; IL-1β and cytokine receptors; IL-6.